Human Psychopharmacology-clinical And Experimental

Journal Title：Human Psychopharmacology-clinical And Experimental

Human Psychopharmacology: Clinical and Experimental provides a forum for the evaluation of clinical and experimental research on both new and established psychotropic medicines. Experimental studies of other centrally active drugs, including herbal products, in clinical, social and psychological contexts, as well as clinical/scientific papers on drugs of abuse and drug dependency will also be considered. While the primary purpose of the Journal is to publish the results of clinical research, the results of animal studies relevant to human psychopharmacology are welcome. The following topics are of special interest to the editors and readers of the Journal:

-All aspects of clinical psychopharmacology-

Efficacy and safety studies of novel and standard psychotropic drugs-

Studies of the adverse effects of psychotropic drugs-

Effects of psychotropic drugs on normal physiological processes-

Geriatric and paediatric psychopharmacology-

Ethical and psychosocial aspects of drug use and misuse-

Psychopharmacological aspects of sleep and chronobiology-

Neuroimaging and psychoactive drugs-

Phytopharmacology and psychoactive substances-

Drug treatment of neurological disorders-

Mechanisms of action of psychotropic drugs-

Ethnopsychopharmacology-

Pharmacogenetic aspects of mental illness and drug response-

Psychometrics: psychopharmacological methods and experimental design

Human Psychopharmacology: Clinical and Experimental 为评估新的和成熟的精神药物的临床和实验研究提供了一个论坛。还将考虑在临床、社会和心理背景下对其他中枢活性药物（包括草药产品）进行的实验研究，以及关于药物滥用和药物依赖的临床/科学论文。虽然该杂志的主要目的是发表临床研究结果，但欢迎与人类精神药理学相关的动物研究结果。本刊的编辑和读者对以下主题特别感兴趣：

-临床精神药理学的各个方面-

新型和标准精神药物的疗效和安全性研究-

精神药物的副作用研究-

精神药物对正常生理过程的影响-

老年和儿科精神药理学-

药物使用和滥用的伦理和社会心理方面-

睡眠和时间生物学的心理药理学方面-

神经影像学和精神药物-

植物药理学和精神活性物质-

神经系统疾病的药物治疗-

精神药物的作用机制-

民族精神药理学-

精神疾病和药物反应的药物遗传学方面-

心理测量学：心理药理学方法和实验设计

Human Psychopharmacology-clinical And Experimental创刊于1986年，由WILEY出版商出版，收稿方向涵盖精神病学 - 医学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度较慢,6-12周，影响因子指数2.112，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。